Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue New England Journal of Medicine Année : 2018

Dates et versions

hal-02346911 , version 1 (05-11-2019)

Identifiants

Citer

Cryptic And The 100,000 Genomes Project Consortium, Philip Supply. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. New England Journal of Medicine, 2018, 379 (15), pp.1403-1415. ⟨10.1056/NEJMoa1800474⟩. ⟨hal-02346911⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More